3/11/2010 StockRing Buy-Sell-Hold Ratings for NASDAQ Biotechnology stocks

Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!
   1. World Markets - 72 Indexes on 3/8/2010:  Buy   76% or 53 Hold   3% or 2 Sell   21% or 15 indexes 2. Dow Jones Index - 30 Stocks on 3/5/2010:  Buy   57% or 17 Hold   30% or 9 Sell   13% or 4 stocks
3. Best Brands - 200 stocks on 2/17/2010:  Buy   81% or 162 Hold   -1% or -2 Sell   20% or 39 stocks
4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341 Hold   21% or 106 Sell   11% or 53 stocks
5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292 Hold   15% or 61 Sell   12% or 47 stocks
6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   20% or 117 Hold   79% or 477 Sell   1% or 6 stocks
7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75 Hold   17% or 17 Sell   8% or 8 stocks
8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81 Hold   35% or 56 Sell   16% or 27 stocks
9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78 Hold   33% or 45 Sell   10% or 13 stocks
10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263 Hold   26% or 115 Sell   14% or 62 stocks
11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109 Hold   6% or 12 Sell   33% or 59 stocks
12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58 Hold   34% or 34 Sell   8% or 8 stocks
13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133 Hold   51% or 176 Sell   11% or 37 funds
14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84 Hold   46% or 73 Sell   2% or 4 funds
15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19 Hold   50% or 47 Sell   30% or 28 stocks
16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111 Hold   34% or 70 Sell   13% or 28 stocks

                                             TOTAL RATINGS:   Buy   74% or 2132 Hold   6% or 1282 Sell   20% or 514 stocks

3/11/2010 StockRing Buy-Sell-Hold ratings for NASDAQ Biotechnology Index stocks
Our advise: SELL 10% or 13, HOLD 33% or 45, BUY 57% or 78 of NASDAQ Index stocks
All Sell & Super Sell Sell Super Sell Hold Buy & Super Buy Buy Super Buy
NASDAQ Biotechnology Index Chart for 1 year 3/11/2010 (Irvine, California) Today StockRing.com analyzed 136 stocks from NASDAQ Biotechnology Index and found that 10% or 13 got a SELL rating. Only 57% or 78 stocks got a BUY rating, while another 33% or 45 stocks got a HOLD rating out of all stocks from NASDAQ Biotechnology Index. Current Market outlook is extremely negative and we anticipate further market declines across all US and most World stocks market indexes. According to our model the government would not be able to compensate the market with enough liquidity to achieve normal operations. This would lead to even more declines in all major stock market sectors. By the way, StockRing found 2 stocks with SUPER SELL rating and 24 stocks with SUPER BUY rating. People who will suffer the most will be the owners of mutual fund shares. According to our scenario mutual funds will not be able quickly exit from their rapidly declining positions and would have to bear the most losses from more active players on the market. Also, a few very well organized stock market players are trading a lot in stock options and are securing currently very high prices for a lot of stocks while anticipating a major decline in their share prices. In the recent year the most profitable strategy was buying put options on all major stocks that consistently declined all year long from S&P 500 index in 2008. At this time StockRing recommends to buy SHORT positions on many stocks from S&P 500 Index stocks that currently have a SELL or SUPER SELL rating. If you decide to take a LONG position and actually buy some stocks right now - please check the section of S&P 500 index stocks that have a BUY or SUPER BUY rating. If you would like to receive Buy-Sell-Hold ratings specifically for your stocks and not just for stocks from S&P 500 Index, then please register for a Free 2 week trial with StockRing.com and begin receiving your weekly reports with Buy-Sell-Hold ratings for all your stocks! StockRing will completely automate your investment steps and quickly calculate which stocks you should SELL right now and which ones to BUY. All you have to do is sit and watch how StockRing software will manage and grow your invested wealth. Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!
3/11/2010 StockRing Buy-Sell-Hold ratings for NASDAQ Biotechnology Index stocks
StockRing advise: SELL 10% or 13, HOLD 33% or 45, BUY 57% or 78 of NASDAQ Index stocks
All Sell & Super Sell Sell Super Sell Hold Buy & Super Buy Buy Super Buy
Symbol	Buy	Hold	Sell	Name	Last Trade		Change		Volume
1. ACAD				BUY - ACADIA Pharmaceuticals Inc. (NGM : ACAD)	Mar 10	1.37	-0.04	-2.84%	707,372
2. ACOR				HOLD - Acorda Therapeutics, Inc. (NGM : ACOR)	Mar 10	34.49	+0.68	+2.01%	636,882
3. ADLR				SELL - Adolor Corporation (NGM : ADLR)	Mar 10	1.88	+0.07	+3.87%	313,743
4. AFFX				HOLD - Affymetrix, Inc. (NasdaqNM : AFFX)	Mar 10	7.94	+0.12	+1.53%	823,378
5. AGEN				HOLD - Antigenics Inc. (NCM : AGEN)	Mar 10	0.77	0.00	0.00%	303,374
6. AKRX				BUY - Akorn, Inc. (NGM : AKRX)	Mar 10	1.64	+0.03	+1.86%	105,561
7. ALKS				BUY - Alkermes, Inc. (NasdaqNM : ALKS)	Mar 10	12.56	-0.36	-2.79%	3,327,815
8. ALNY				HOLD - Alnylam Pharmaceuticals, Inc. (NasdaqNM : ALNY)	Mar 10	18.32	+0.16	+0.88%	145,020
9. ALTH				HOLD - Allos Therapeutics, Inc. (NGM : ALTH)	Mar 10	7.81	+0.49	+6.69%	3,108,699
10. ALTU				HOLD - Altus Pharmaceuticals Inc. (NGM : ALTU)	N/A	0.00	0.00	0.00%
11. ALXA				BUY - Alexza Pharmaceuticals, Inc. (NGM : ALXA)	Mar 10	2.76	+0.04	+1.47%	57,619
12. ALXN				BUY - Alexion Pharmaceuticals, Inc. (NasdaqNM : ALXN)	Mar 10	53.76	+0.28	+0.52%	677,374
13. AMAG				HOLD - AMAG Pharmaceuticals, Inc. (NGM : AMAG)	Mar 10	36.30	+1.48	+4.25%	734,836
14. AMGN				SUPER BUY - Amgen Inc. (NasdaqNM : AMGN)	Mar 10	57.78	+0.02	+0.03%	4,620,621
15. AMLN				SUPER BUY - Amylin Pharmaceuticals, Inc. (NasdaqNM : AMLN)	Mar 10	20.90	+1.27	+6.47%	8,201,081
16. AMRI				BUY - Albany Molecular Research, Inc. (NasdaqNM : AMRI)	Mar 10	8.71	-0.05	-0.57%	46,859
17. ANPI				HOLD - Angiotech Pharmaceuticals, Inc. (NasdaqNM : ANPI)	Mar 10	1.13	0.00	0.00%	532,449
18. ARIA				HOLD - ARIAD Pharmaceuticals, Inc. (NGM : ARIA)	Mar 10	3.03	+0.07	+2.36%	4,292,641
19. ARNA				BUY - Arena Pharmaceuticals, Inc. (NGM : ARNA)	Mar 10	3.11	0.00	0.00%	1,987,620
20. ARQL				BUY - ArQule, Inc. (NGM : ARQL)	Mar 10	3.53	+0.02	+0.57%	130,895
21. ARRY				BUY - Array BioPharma Inc. (NGM : ARRY)	Mar 10	2.48	+0.03	+1.22%	132,462
22. AUXL				BUY - Auxilium Pharmaceuticals, Inc. (NasdaqNM : AUXL)	Mar 10	33.41	+1.49	+4.67%	1,229,485
23. AVII				BUY - AVI BioPharma, Inc. (NGM : AVII)	Mar 10	1.32	+0.02	+1.54%	750,279
24. BCRX				HOLD - BioCryst Pharmaceuticals, Inc. (NGM : BCRX)	Mar 10	7.28	+0.27	+3.85%	512,834
25. BIIB				HOLD - Biogen Idec Inc (NasdaqNM : BIIB)	Mar 10	58.71	+0.87	+1.50%	2,248,526
26. BIOD				BUY - Biodel Inc. (NGM : BIOD)	Mar 10	4.37	+0.01	+0.23%	80,752
27. BJGP				BUY - BMP Sunstone Corporation (NGM : BJGP)	Mar 10	5.72	-0.03	-0.52%	65,198
28. BMRN				SELL - BioMarin Pharmaceutical Inc. (NasdaqNM : BMRN)	Mar 10	23.00	+0.88	+3.98%	2,062,963
29. BMTI				HOLD - BioMimetic Therapeutics, Inc. (NGM : BMTI)	Mar 10	12.21	+0.06	+0.49%	46,622
30. CADX				BUY - Cadence Pharmaceuticals, Inc. (NGM : CADX)	Mar 10	9.51	+0.13	+1.39%	184,683
31. CALP				HOLD - Caliper Life Sciences Inc (NGM : CALP)	Mar 10	3.60	+0.06	+1.69%	39,469
32. CBRX				SELL - Columbia Laboratories, Inc. (NGM : CBRX)	Mar 10	1.03	-0.05	-4.63%	540,501
33. CBST				BUY - Cubist Pharmaceuticals, Inc. (NasdaqNM : CBST)	Mar 10	22.29	+0.27	+1.23%	451,592
34. CEGE				HOLD - Cell Genesys, Inc. (NGM : CEGE)	N/A	0.36	0.00	0.00%
35. CELG				BUY - Celgene Corporation (NasdaqNM : CELG)	Mar 10	61.91	+0.15	+0.24%	1,928,795
36. CEPH				BUY - Cephalon, Inc. (NasdaqNM : CEPH)	Mar 10	71.53	+0.73	+1.03%	1,195,569
37. CERS				HOLD - Cerus Corporation (NGM : CERS)	Mar 10	2.63	-0.01	-0.38%	480,233
38. CRA				SELL - Celera Corporation (NasdaqNM : CRA)	Mar 10	6.57	+0.09	+1.39%	664,983
39. CRME				HOLD - Cardiome Pharma Corporation (NGM : CRME)	Mar 10	6.05	+0.42	+7.46%	457,117
40. CRXL				SUPER BUY - Crucell NV (NasdaqNM : CRXL)	Mar 10	21.03	+0.24	+1.15%	87,816
41. CRXX				HOLD - CombinatoRx, Incorporated (NGM : CRXX)	Mar 10	1.24	-0.02	-1.59%	1,673,809
42. CVTX				HOLD - CV Therapeutics, Inc. (NasdaqNM : CVTX)	N/A	0.00	0.00	0.00%
43. CYPB				BUY - Cypress Bioscience, Inc. (NGM : CYPB)	Mar 10	4.90	-0.06	-1.21%	328,773
44. CYTK				BUY - Cytokinetics, Incorporated (NGM : CYTK)	Mar 10	3.36	+0.03	+0.90%	679,426
45. DEPO				SUPER BUY - Depomed, Inc. (NGM : DEPO)	Mar 10	3.20	-0.01	-0.31%	502,989
46. DNDN				HOLD - Dendreon Corporation (NGM : DNDN)	Mar 10	35.99	-0.42	-1.15%	3,672,591
47. DRRX				HOLD - Durect Corporation (NGM : DRRX)	Mar 10	2.80	+0.08	+2.94%	195,295
48. DSCO				HOLD - Discovery Laboratories, Inc. (NGM : DSCO)	Mar 10	0.54	-0.015	-2.70%	2,224,505
49. DYAX				SUPER BUY - Dyax Corp. (NGM : DYAX)	Mar 10	3.93	+0.01	+0.26%	194,706
50. ENDP				BUY - Endo Pharmaceuticals Holdings I (NasdaqNM : ENDP)	Mar 10	23.49	-0.01	-0.04%	1,096,805
51. ENZN				BUY - Enzon Pharmaceuticals, Inc. (NGM : ENZN)	Mar 10	10.31	+0.46	+4.67%	1,303,491
52. EURX				BUY - Eurand N.V. (NGM : EURX)	Mar 10	10.00	+0.24	+2.46%	143,136
53. EXEL				BUY - Exelixis, Inc. (NasdaqNM : EXEL)	Mar 10	6.18	-0.13	-2.06%	1,980,189
54. FLML				BUY - Flamel Technologies S.A. (NGM : FLML)	Mar 10	7.59	+0.01	+0.13%	15,248
55. GENZ				SUPER SELL - Genzyme Corporation (NasdaqNM : GENZ)	Mar 10	57.60	+0.15	+0.26%	1,847,323
56. GERN				SUPER BUY - Geron Corporation (NGM : GERN)	Mar 10	6.16	+0.11	+1.82%	1,551,677
57. GHDX				SELL - Genomic Health, Inc. (NGM : GHDX)	Mar 10	19.20	-0.24	-1.23%	212,278
58. GILD				BUY - Gilead Sciences, Inc. (NasdaqNM : GILD)	Mar 10	47.28	-0.16	-0.34%	6,355,585
59. GNVC				BUY - GenVec, Inc. (NGM : GNVC)	Mar 10	2.82	-0.23	-7.54%	8,695,126
60. GPRO				HOLD - Gen-Probe Incorporated (NasdaqNM : GPRO)	Mar 10	46.85	+0.12	+0.26%	179,814
61. GTXI				HOLD - GTx, Inc. (NGM : GTXI)	Mar 10	3.66	-0.13	-3.43%	274,017
62. HALO				HOLD - Halozyme Therapeutics, Inc. (NGM : HALO)	Mar 10	7.27	+0.16	+2.25%	1,722,993
63. HBIO				BUY - Harvard Bioscience, Inc. (NGM : HBIO)	Mar 10	3.89	+0.08	+2.10%	57,678
64. HGSI				HOLD - Human Genome Sciences, Inc. (NGM : HGSI)	Mar 10	32.56	+0.75	+2.36%	3,268,405
65. HITK				SUPER BUY - Hi-Tech Pharmacal Co., Inc. (NasdaqNM : HITK)	Mar 10	25.50	+0.53	+2.12%	260,490
66. IDEV				HOLD - Indevus Pharmaceuticals Inc. (NasdaqNM : IDEV)	N/A	0.00	0.00	0.00%
67. IDIX				HOLD - Idenix Pharmaceuticals, Inc. (NGM : IDIX)	Mar 10	2.84	+0.03	+1.07%	190,732
68. ILMN				BUY - Illumina, Inc. (NasdaqNM : ILMN)	Mar 10	39.44	+0.44	+1.13%	1,213,047
69. IMGN				BUY - ImmunoGen, Inc. (NGM : IMGN)	Mar 10	7.51	+0.05	+0.67%	405,868
70. IMMU				HOLD - Immunomedics, Inc. (NGM : IMMU)	Mar 10	3.49	+0.04	+1.16%	1,081,698
71. INCY				SUPER BUY - Incyte Corporation (NGM : INCY)	Mar 10	12.42	-0.17	-1.35%	3,493,374
72. ISIS				BUY - Isis Pharmaceuticals, Inc. (NasdaqNM : ISIS)	Mar 10	10.05	+0.93	+10.20%	6,209,031
73. ISPH				BUY - Inspire Pharmaceuticals, Inc. (NGM : ISPH)	Mar 10	6.77	+0.12	+1.80%	772,200
74. ITMN				HOLD - InterMune, Inc. (NasdaqNM : ITMN)	Mar 10	38.39	+15.09	+64.76%	15,481,040
75. LGND				HOLD - Ligand Pharmaceuticals Incorpor (NGM : LGND)	Mar 10	1.70	0.00	0.00%	396,462
76. LIFE				SUPER BUY - Life Technologies Corporation (NasdaqNM : LIFE)	Mar 10	52.28	+0.10	+0.19%	2,614,478
77. LMNX				HOLD - Luminex Corporation (NGM : LMNX)	Mar 10	16.46	+0.11	+0.67%	156,165
78. LXRX				BUY - Lexicon Pharmaceuticals, Inc. (NGM : LXRX)	Mar 10	1.64	+0.06	+3.80%	1,004,940
79. MAXY				BUY - Maxygen, Inc. (NGM : MAXY)	Mar 10	5.99	+0.12	+2.04%	139,717
80. MBRK				BUY - MiddleBrook Pharmaceuticals, In (NGM : MBRK)	Mar 10	0.49	+0.02	+4.26%	884,808
81. MDCO				HOLD - Medicines Company (The) (NasdaqNM : MDCO)	Mar 10	8.22	+0.11	+1.36%	795,723
82. MDVN				BUY - Medivation, Inc. (NGM : MDVN)	Mar 10	12.66	+0.56	+4.63%	3,991,809
83. MEDX				HOLD - Medarex, Inc. (NGM : MEDX)	N/A	0.00	0.00	0.00%
84. MGRM				HOLD - Monogram Biosciences, Inc. (NGM : MGRM)	N/A	0.00	0.00	0.00%
85. MITI				SUPER BUY - Micromet, Inc. (NGM : MITI)	Mar 10	8.03	-0.06	-0.74%	367,388
86. MNKD				BUY - MannKind Corporation (NGM : MNKD)	Mar 10	10.48	+0.07	+0.67%	892,467
87. MNTA				SELL - Momenta Pharmaceuticals, Inc. (NGM : MNTA)	Mar 10	15.02	-0.09	-0.60%	232,178
88. MTXX				HOLD - Matrixx Initiatives Inc. (NasdaqNM : MTXX)	Mar 10	4.76	-0.07	-1.45%	106,654
89. MYGN				HOLD - Myriad Genetics, Inc. (NasdaqNM : MYGN)	Mar 10	22.85	-0.12	-0.52%	2,221,710
90. NABI				SUPER SELL - Nabi Biopharmaceuticals (NGM : NABI)	Mar 10	5.70	+0.14	+2.52%	306,943
91. NBIX				HOLD - Neurocrine Biosciences, Inc. (NasdaqNM : NBIX)	Mar 10	2.38	+0.02	+0.85%	331,480
92. NKTR				SUPER BUY - Nektar Therapeutics (NasdaqNM : NKTR)	Mar 10	15.36	+0.07	+0.46%	1,004,312
93. NOVN				HOLD - Noven Pharmaceuticals, Inc. (NasdaqNM : NOVN)	N/A	0.00	0.00	0.00%
94. NPSP				HOLD - NPS Pharmaceuticals, Inc. (NGM : NPSP)	Mar 10	4.00	+0.04	+1.01%	160,836
95. NVAX				BUY - Novavax, Inc. (NGM : NVAX)	Mar 10	2.40	+0.04	+1.69%	772,305
96. OMPI				SUPER BUY - Obagi Medical Products, Inc. (NasdaqNM : OMPI)	Mar 10	11.89	+0.07	+0.59%	51,537
97. ONXX				SUPER BUY - ONYX Pharmaceuticals, Inc. (NasdaqNM : ONXX)	Mar 10	30.61	+0.29	+0.96%	1,046,374
98. OPTR				SUPER BUY - Optimer Pharmaceuticals, Inc. (NGM : OPTR)	Mar 10	13.65	+0.09	+0.66%	112,734
99. OREX				SUPER BUY - Orexigen Therapeutics, Inc. (NGM : OREX)	Mar 10	6.50	-0.01	-0.15%	393,592
100. OSIP				BUY - OSI Pharmaceuticals Inc. (NasdaqNM : OSIP)	Mar 10	57.75	+0.75	+1.32%	2,072,202
101. OSIR				HOLD - Osiris Therapeutics, Inc. (NGM : OSIR)	Mar 10	7.80	+0.30	+4.00%	104,955
102. PDLI				SUPER BUY - PDL BioPharma, Inc. (NasdaqNM : PDLI)	Mar 10	7.29	+0.19	+2.68%	4,363,688
103. PGNX				SELL - Progenics Pharmaceuticals Inc. (NGM : PGNX)	Mar 10	4.91	+0.20	+4.25%	129,056
104. POZN				BUY - Pozen, Inc. (NGM : POZN)	Mar 10	7.03	+0.10	+1.44%	138,838
105. PRGO				SUPER BUY - Perrigo Company (NasdaqNM : PRGO)	Mar 10	50.10	+0.77	+1.56%	903,411
106. PTIE				SELL - Pain Therapeutics (NasdaqNM : PTIE)	Mar 10	6.20	-0.05	-0.80%	143,234
107. QGEN				SUPER BUY - Qiagen N.V. (NasdaqNM : QGEN)	Mar 10	22.61	+0.26	+1.16%	615,284
108. QLTI				BUY - QLT Inc. (NasdaqNM : QLTI)	Mar 10	4.87	-0.06	-1.22%	249,497
109. REGN				BUY - Regeneron Pharmaceuticals, Inc. (NasdaqNM : REGN)	Mar 10	25.78	+0.13	+0.51%	558,007
110. RIGL				BUY - Rigel Pharmaceuticals, Inc. (NGM : RIGL)	Mar 10	7.54	-0.17	-2.20%	477,335
111. SEPR				HOLD - Sepracor Inc. (NasdaqNM : SEPR)	N/A	22.85	0.00	0.00%
112. SGEN				BUY - Seattle Genetics, Inc. (NGM : SGEN)	Mar 10	11.73	-0.03	-0.26%	490,801
113. SGMO				SUPER BUY - Sangamo BioSciences, Inc. (NGM : SGMO)	Mar 10	5.90	+0.03	+0.51%	216,225
114. SHPGY				HOLD - Shire plc (NasdaqNM : SHPGY)	Mar 10	65.82	-0.1025	-0.16%	401,746
115. SLXP				BUY - Salix Pharmaceuticals, Ltd. (NasdaqNM : SLXP)	Mar 10	31.49	+0.26	+0.83%	1,257,597
116. SNTA				HOLD - Synta Pharmaceuticals Corp. (NGM : SNTA)	Mar 10	4.53	+0.07	+1.57%	210,047
117. SNTS				BUY - Santarus, Inc. (NGM : SNTS)	Mar 10	4.63	+0.085	+1.87%	404,532
118. SQNM				BUY - Sequenom, Inc. (NGM : SQNM)	Mar 10	7.73	+0.12	+1.58%	4,682,800
119. STEM				HOLD - StemCells, Inc. (NGM : STEM)	Mar 10	1.22	+0.01	+0.83%	1,651,847
120. SUPG				HOLD - SuperGen, Inc. (NGM : SUPG)	Mar 10	2.94	-0.05	-1.67%	172,199
121. SVNT				SUPER BUY - Savient Pharmaceuticals Inc (NGM : SVNT)	Mar 10	14.85	+0.49	+3.41%	1,183,616
122. TECH				BUY - Techne Corporation (NasdaqNM : TECH)	Mar 10	65.12	+0.09	+0.14%	179,515
123. TELK				BUY - Telik, Inc. (NCM : TELK)	Mar 10	0.87	+0.01	+1.16%	63,158
124. TEVA				SUPER BUY - Teva Pharmaceutical Industries (NasdaqNM : TEVA)	Mar 10	60.94	-0.54	-0.88%	3,604,924
125. THRX				HOLD - Theravance, Inc. (NGM : THRX)	Mar 10	12.72	-0.01	-0.08%	208,015
126. TRMS				HOLD - Trimeris, Inc. (NGM : TRMS)	Mar 10	2.46	+0.02	+0.82%	23,134
127. UTHR				BUY - United Therapeutics Corporation (NasdaqNM : UTHR)	Mar 10	59.67	+0.57	+0.96%	399,323
128. VNDA				HOLD - Vanda Pharmaceuticals Inc. (NGM : VNDA)	Mar 10	11.52	+1.17	+11.30%	3,718,912
129. VPHM				BUY - ViroPharma Incorporated (NasdaqNM : VPHM)	Mar 10	13.10	+0.03	+0.23%	982,478
130. VRTX				BUY - Vertex Pharmaceuticals Incorpor (NasdaqNM : VRTX)	Mar 10	43.02	+0.94	+2.23%	3,011,985
131. VRUS				SUPER BUY - Pharmasset, Inc. (NGM : VRUS)	Mar 10	23.01	+0.56	+2.49%	94,398
132. VVUS				SUPER BUY - VIVUS, Inc. (NGM : VVUS)	Mar 10	9.42	+0.24	+2.61%	2,371,521
133. WCRX				SUPER BUY - Warner Chilcott Limited (NasdaqNM : WCRX)	Mar 10	27.07	-0.36	-1.31%	918,344
134. XNPT				HOLD - XenoPort, Inc. (NasdaqNM : XNPT)	Mar 10	8.76	+0.34	+4.04%	3,635,933
135. XOMA				SELL - XOMA Ltd. (NGM : XOMA)	Mar 10	0.5521	-0.0079	-1.41%	2,211,866
136. ZGEN				BUY - ZymoGenetics, Inc. (NGM : ZGEN)	Mar 10	6.15	+0.12	+1.99%	162,857
3/11/2010 StockRing Buy-Sell-Hold ratings for NASDAQ Biotechnology Index stocks
StockRing advise: SELL 10% or 13, HOLD 33% or 45, BUY 57% or 78 of NASDAQ Index stocks
All Sell & Super Sell Sell Super Sell Hold Buy & Super Buy Buy Super Buy
Last Changes: Thu, Mar 11, 2010

3/11/2010 StockRing Business News about NASDAQ-BIO Stock Market Index

RTT News

Biotechnology M&As, Wholesale Mix the Markets and ETFs
ETF Trends (blog)
Abbott Laboratories (NYSE: ABT) is going to buy Facet Biotech Corp. (NASDAQ: FACT) for $450 million. Abbott's bid bested a failed bid from Biogen Idec Inc. ...
Biotech ETF Sheds 'Stigma,' Hits 8-Year HighCNBC
Facet, InterMune lead drug stocks northMarketWatch
Facet Biotech Skyrockets on Acquisition by Abbott Labs (FACT,ABT)FOXBusiness
BioWorld Online -PR-inside.com (press release)
all 479 news articles »

ETF Trends (blog)

ETF Spotlight: First Trust NYSE Arca Biotechnology (FBT)
ETF Trends (blog)
Abbott Laboratories (NYSE: ABT) is going to buy Facet Biotech Corp. (NASDAQ: FACT) for $450 million. Abbott's bid bested a failed bid from Biogen Idec Inc. ...
Biotech ETF Surges Again: The FBT and InterMune (ITMN)ONN.tv
Five ETFs Leading The New UptrendInvestor's Business Daily
Benzinga's Top ETF Gainers (FBT, FAS, USD, KBE)Benzinga
TheStreet.com (subscription) -Before It's News
all 9 news articles »

For Biotech in 2010, It's Déjà Vu All Over Again
Seeking Alpha (blog)
The NASDAQ Biotech Index, which traded as high as 772 during the first week of February, traded as low as 605 by the first week of March – losing more than ...

Biotech Singles and Homeruns: The FBT vs. OSI Pharmaceuticals (OSIP)
ONN.tv
There I explained why owning this ETF gave biotech investors decent exposure to small-cap names such as Human Genome Sciences (NASDAQ: HGSI) that vaulted ...
Some Biotech ETFs Win, Others LoseTheStreet.com (subscription)
Monday's ETF Movers: FBT, PWNDMarketNewsVideo.com

all 5 news articles »

Reuters

US Stocks Tread Water As Commodities Retreat Weighs
Wall Street Journal
Among stocks to watch, Facet Biotech jumped 66% as Abbott Laboratories agreed to acquire the biotechnology company for $722 million. ...
Financials, Tech Lead US Stocks Higher After Inventory DataWall Street Journal
BEFORE THE BELL: US Stock Futures Mixed On Little FocusWall Street Journal

all 1,395 news articles »

US HOT STOCKS:Men's Wearhouse, Hot Topic Active In Late Trading
Wall Street Journal
Biotechnology company Facet had been soliciting suitors since rejecting that offer, which last stood at $17.50. Facet shareholders will get a bigger dowry ...

and more »

US Stocks Rise As Inventory Data Shows Demand; DJIA Up 24
Wall Street Journal
Facet Biotech jumped 66% as Abbott Laboratories agreed to acquire the biotechnology company for $722 million. Facet shareholders will get $27 a share, ...

and more »

3SBio Announces Changes to its Board of Directors
PR Newswire (press release)
SHENYANG, China, March 10 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, ...
3SBio Inc reports retirement of executive director and vice presidentTrading Markets (press release)
3SBio says co-founder Xu is retiring from boardBusinessWeek

all 26 news articles »

Franklin Fund turns more aggressive on biotech
MarketWatch
The Nasdaq Biotechnology index dropped 35% between August 2008 and March 2009. McCulloch saw an opportunity to pivot and cut back on stocks like Shire and ...

RxNews Recap for Wednesday 03-10-10
BioMedReports (subscription)
3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products ...

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech (redOrbit) ABBOTT PARK, Ill. and REDWOOD CITY, Calif., March 9 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Facet Biotech Corporation (Nasdaq: FACT) announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.

Facet Biotech Wooed by $722M Acquisition Offer from Abbott (BioWorld) Three months after Biogen Idec Inc. failed to acquire Facet Biotech Corp. for $17.50 per share, Abbott is getting the job done with a $27-per-share offer.

Clal Biotech posts full year profit (Globes Online) Capital gains came primarily from D-Pharm's IPO and Teva's exercise of an option in Andromeda Biotech.

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech (PR Newswire via Yahoo! Finance) Abbott and Facet Biotech Corporation announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline. Â Abbott will acquire Facet for $27 per share in cash for a net transaction value of approximately $450 million, which includes a purchase price of approximately $722 million less Facet's projected cash and marketable securities ...

Oncolytics Biotech(R) Inc. Announces 2009 Year End Results (CNW Group via Yahoo! Finance) Oncolytics Biotech Inc. today announced its financial results and operational highlights for the year ended December 31, 2009.

U.S. Stock-Index Futures Fluctuate; Facet, Citigroup Advance (Bloomberg) March 10 (Bloomberg) -- U.S. stock-index futures fluctuated after the Standard & Poor’s 500 Index closed at a seven-week high yesterday. Facet Biotech Corp.

U.S. Stock-Index Futures Little Changed; Facet, Citigroup Rise (Bloomberg) March 10 (Bloomberg) -- U.S. stock-index futures were little changed after the Standard & Poor’s 500 Index closed at a seven-week high yesterday. Facet Biotech Corp.

OSI Bid Likely to Rise as Astellas Seeks Cancer Sales (Update3) (Bloomberg) March 9 (Bloomberg) -- OSI Pharmaceuticals Inc .’s status as one of the few U.S. biotechnology companies with income from an approved cancer drug likely will drive up the price Tokyo-based Astellas Pharma Inc.

U.S. stocks gain as investors bid up banks (MarketWatch via Yahoo! Finance) U.S. stocks edge higher for a second straight day thanks to a rally in the financial sector led by American International Group and Citigroup, which conducted a successful offering of $2 billion in securities.

OSI Bid Likely to Rise as Astellas Seeks Cancer Sales (Update4) (BusinessWeek) OSI Pharmaceuticals Inc.’s status as one of the few U.S. biotechnology companies with income from an approved cancer drug likely will drive up the price Tokyo-based Astellas Pharma Inc. must pay to acquire it.

   1. World Markets - 72 Indexes on 3/8/2010:  Buy   76% or 53 Hold   3% or 2 Sell   21% or 15 indexes 2. Dow Jones Index - 30 Stocks on 3/5/2010:  Buy   57% or 17 Hold   30% or 9 Sell   13% or 4 stocks
3. Best Brands - 200 stocks on 2/17/2010:  Buy   81% or 162 Hold   -1% or -2 Sell   20% or 39 stocks
4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341 Hold   21% or 106 Sell   11% or 53 stocks
5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292 Hold   15% or 61 Sell   12% or 47 stocks
6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   20% or 117 Hold   79% or 477 Sell   1% or 6 stocks
7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75 Hold   17% or 17 Sell   8% or 8 stocks
8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81 Hold   35% or 56 Sell   16% or 27 stocks
9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78 Hold   33% or 45 Sell   10% or 13 stocks
10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263 Hold   26% or 115 Sell   14% or 62 stocks
11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109 Hold   6% or 12 Sell   33% or 59 stocks
12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58 Hold   34% or 34 Sell   8% or 8 stocks
13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133 Hold   51% or 176 Sell   11% or 37 funds
14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84 Hold   46% or 73 Sell   2% or 4 funds
15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19 Hold   50% or 47 Sell   30% or 28 stocks
16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111 Hold   34% or 70 Sell   13% or 28 stocks

                                             TOTAL RATINGS:   Buy   74% or 2132 Hold   6% or 1282 Sell   20% or 514 stocks

Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!